DADC
ARRY

D.A. Davidson & Co’s Array Biopharma Inc ARRY Stock Holding History

D.A. Davidson & Co’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-294
Closed -$2K – 2240
2017
Q2 		$2K Hold
294
– – ﹤0.01% 2310
2017
Q1 		$2K Hold
294
– – ﹤0.01% 2281
2016
Q4 		$2K Hold
294
– – ﹤0.01% 2372
2016
Q3 		$1K Hold
294
– – ﹤0.01% 2357
2016
Q2 		$1K Hold
294
– – ﹤0.01% 2312
2016
Q1 		$0 Hold
294
– – ﹤0.01% 2383
2015
Q4 		$1K Hold
294
– – ﹤0.01% 2196
2015
Q3 		$1K Hold
294
– – ﹤0.01% 2167
2015
Q2 		$2K Hold
294
– – ﹤0.01% 2134
2015
Q1 		$2K Hold
294
– – ﹤0.01% 2018
2014
Q4 		$1K Hold
294
– – ﹤0.01% 2074
2014
Q3 		$1K Hold
294
– – ﹤0.01% 2082
2014
Q2 		$1K Hold
294
– – ﹤0.01% 2072
2014
Q1 		$1K Sell
294
-685
-70% -$3.44K ﹤0.01% 2077
2013
Q4 		$4K Buy
+979
New +$5.33K ﹤0.01% 1908

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

D.A. Davidson & Co's ARRY Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Array Biopharma Inc (ARRY) in Q3 2017, closing a stake of 294 shares — an estimated $2K sold.

D.A. Davidson & Co first reported a position in ARRY in Q4 2013 and held it in 15 quarters. The position peaked at $4K in Q4 2013. 184 funds tracked by Wall St. Rank hold ARRY as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Array Biopharma Inc position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 294 Array Biopharma Inc shares in Q3 2017, an estimated $2K.
  • D.A. Davidson & Co first reported a position in Array Biopharma Inc in Q4 2013 and held it in 15 quarters.
  • D.A. Davidson & Co's Array Biopharma Inc position peaked at $4K in Q4 2013.
  • 184 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.